Targets › MAGEA4
6 programs from 6 companies in 7 trials: 6 Phase 1, 1 Phase 2; Oncology; next expected readout Dec 2026.
Regulates cell proliferation through the inhibition of cell cycle arrest at the G1 phase. Also negatively regulates p53-mediated apoptosis. (UniProt, P43358)
Open in Phaseline: the race on MAGEA4, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| USWM CT | Afamitresgene Autoleucel Melanoma-associated antigen 4 binding agent | MAGEA4 | Phase 2 | Synovial Sarcoma | Apr 2038 |
| CDR-Life | CDR404 T-cell engaging bispecific antibody targeting MAGE-A4 | MAGEA4 | Phase 1 | Select Advanced Solid Tumors | Dec 2026 |
| Zelluna Immunotherapy | ZI-MA4-1 Allogeneic TCR-engineered NK cells targeting MAGE-A4 | MAGEA4 | Phase 1 | Ovarian Cancer | Dec 2028 |
| Peking University | TCR-MAGE-A4 T-Cells MAGE-A4-directed T cell receptor-engineered T cells | MAGEA4 | Phase 1 | Advanced Solid Tumor | Dec 2028 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | TCR-T cells targeting MAGE-A4 TCR-engineered T cells targeting MAGE-A4, a cancer-testis antigen | MAGEA4 | Phase 1 | Advanced Mesenchymal Malignancies | Dec 2029 |
| PDC*line Pharma SAS | PDC*lung01 Dendritic cell vaccine loaded with synthetic peptides from lung tumor antigens (NY-ESO-1, | PRAME, MAGEA3, MAGEA4 | Phase 1 | Non Small Cell Lung Cancer | – |
Synovial Sarcoma (2) Ovarian Cancer (1) Non Small Cell Lung Cancer (1) Advanced Solid Tumor (1) Select Advanced Solid Tumors (1) Advanced Mesenchymal Malignancies (1)
other (3), mixed (2), protein or peptide (1)
Zelluna Immunotherapy (1) PDC*line Pharma SAS (1) Peking University (1) CDR-Life (1) USWM CT (1) Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.